21 Nov 2018

ACP CHANGES ITS NAME TO AMERICAN VEIN & LYMPHATIC SOCIETY; AVLS OFFICIAL STATEMENT

By Vanessa Salvia The American College of Phlebology (ACP) has changed its name to the American Vein & Lymphatic Society (AVLS). The organization is still working on its new logo. The American College of Phlebology Foundation will be known as the Foundation for Venous and Lymphatic Disease, or FVLD. During

0
21 Nov 2018

BOSTON SCIENTIFIC ACQUIRING BTG

    Boston Scientific has reached an agreement on the terms of a recommended offer to acquire BTG plc., a United Kingdom-based company that develops and commercializes products used in minimally-invasive procedures, targeting vascular diseases and cancer, as well as acute care pharmaceuticals. Under the terms of the transaction, holders

0
13 Nov 2018

VIETHsymposium: INTACT VASCULAR EVENTS

Intact Vascular Inc., a private medical device company committed to developing solutions for minimally invasive peripheral vascular procedures, has announced the schedule of key presentations to be featured during a lunch symposium co-sponsored with Philips at the 45th annual VEITHsymposium in New York City on Thursday, Nov.15. Following the symposium, an

0
12 Nov 2018

26,000-PERSON STUDY: FISH OIL AND VITAMIN D PILLS NO GUARD AGAINST CANCER OR SERIOUS HEART TROUBLE

By Liz Szabo Kaiser Health News A widely anticipated study has concluded that neither vitamin D nor fish oil supplements prevent cancer or serious heart-related problems in healthy older people, according to research presented Nov. 10 at the American Heart Association Scientific Sessions. Researchers defined serious heart problems as the

0
06 Nov 2018

SYMANTEC BLOG POST: HEALTHCARE MAKES UP ONE-QUARTER OF SAMSAM RANSOMWARE ATTACKS

Healthcare organizations have accounted for one-quarter of SamSam ransomware attack victims so far this year, said security firm Symantec in a recent blog post. In total, 67 different organizations across sectors have been attacked by the SamSam ransomware, with 56 of those attacks located in the United States, Symantec related. “Why healthcare

0
23 Oct 2018

EARL E. BAKKEN: MEDTRONICS CO-FOUNDER DIES AT 94

Earl E. Bakken, co-founder  of Medtronic plc, passed away peacefully on Oct. 21 at his home on Kiholo Bay on the Big Island of Hawaii. He was 94 years old. “Today we are saddened by the passing of Earl Bakken, but we also honor and will forever cherish the life

0
28 Sep 2018

STUDY DEMOS EDUCATIONAL VIDEOS IMPROVES PATIENT CONSENT PROCESS, SAVES TIME, DECREASES PHYSICIAN BURNOUT  

The School of Medicine at Emory University has published a study suggesting that educational videos significantly improve the patient consent process versus traditional face-to-face methods.   The physicians who participated in the study also believed that they spent less time during the face-to-face portion of the consent process following video

0
10 Aug 2018

GLOBAL ULTRASOUND DEVICES MARKET ANALYZED THROUGH 2023

           A global ultrasound devices market report has added to the Research and Markets  offering. According to the “Global Ultrasound Devices Market — Segmented by Application, Technology, Type, and Geography – Growth, Trends, and Forecast (2018-2023)” report, the market is expected to register a CAGR of about 4 percent during 2018-2023. The

0
09 Aug 2018

METACTIVE TOUTS PERIPHERAL ARTERY RESEARCH RESULTS

Metactive Medical Inc., a Kansas medical device company developing products for the treatment of neurovascular and peripheral vascular diseases, announced today that Kieran Murphy, professor, vice chair and director of research in the department of Medical Imaging at the University of Toronto, presented new nonclinical results from Metactive’s peripheral vascular

0
07 Aug 2018

MICROSOFT IS DEVELOPING A GLASSES-BASED BLOOD PRESSURE MONITOR

            Microsoft is developing new blood pressure monitoring technology called Glabella, which comes equipped on a pair of glasses that passively collects physiological data on the wearer, according to a research paper recently released by the company. The paper was written by Christian Holz, Microsoft Research in Redmond; and  Edward J.

0